Terms: = Brain cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
13 results:
1. TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor nono.
Chen Y; Xu X; Ding K; Tang T; Cai F; Zhang H; Chen Z; Qi Y; Fu Z; Zhu G; Dou Z; Xu J; Chen G; Wu Q; Ji J; Zhang J
J Exp Clin Cancer Res; 2024 Feb; 43(1):39. PubMed ID: 38303029
[TBL] [Abstract] [Full Text] [Related]
2. Targeting the splicing factor nono inhibits GBM progression through GPX1 intron retention.
Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
[No Abstract] [Full Text] [Related]
3. ABO blood group type and risk of venous thromboembolism in patients with cancer.
Englisch C; Moik F; Nopp S; Raderer M; Pabinger I; Ay C
Blood Adv; 2022 Dec; 6(24):6274-6281. PubMed ID: 35416922
[TBL] [Abstract] [Full Text] [Related]
4. Paraspeckle Protein nono Promotes TAZ Phase Separation in the Nucleus to Drive the Oncogenic Transcriptional Program.
Wei Y; Luo H; Yee PP; Zhang L; Liu Z; Zheng H; Zhang L; Anderson B; Tang M; Huang S; Li W
Adv Sci (Weinh); 2021 Dec; 8(24):e2102653. PubMed ID: 34716691
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme.
Sokmen FC; Karacin C
J Coll Physicians Surg Pak; 2020 Jul; 30(7):713-716. PubMed ID: 32811600
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
Heenkenda MK; Malmström A; Lysiak M; Mudaisi M; Bratthäll C; Milos P; Strandeus M; Åkesson L; Söderkvist P; Uppugunduri S; Osman A
Thromb Res; 2019 Nov; 183():136-142. PubMed ID: 31677594
[TBL] [Abstract] [Full Text] [Related]
7. Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases.
Ahmed KA; Kim S; Arrington J; Naghavi AO; Dilling TJ; Creelan BC; Antonia SJ; Caudell JJ; Harrison LB; Sahebjam S; Gray JE; Etame AB; Johnstone PA; Yu M; Perez BA
J Neurooncol; 2017 Jun; 133(2):331-338. PubMed ID: 28466250
[TBL] [Abstract] [Full Text] [Related]
8. GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status.
Pérez-Segura P; Manneh R; Ceballos I; García A; Benavides M; Fuster J; Vaz MA; Cano JM; Berros JP; Covela M; Moreno V; Quintanar T; García Bueno JM; Fernández I; Sepúlveda J
Clin Transl Oncol; 2016 Aug; 18(8):805-12. PubMed ID: 26542177
[TBL] [Abstract] [Full Text] [Related]
9. "No-no" type bobble-head doll syndrome in an infant with an arachnoid cyst of the posterior fossa: a case report.
Ishihara M; Nonaka M; Oshida N; Hamada Y; Nakajima S; Yamasaki M
Pediatr Neurol; 2013 Dec; 49(6):474-6. PubMed ID: 24075844
[TBL] [Abstract] [Full Text] [Related]
10. Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro.
Bernhart E; Damm S; Wintersperger A; DeVaney T; Zimmer A; Raynham T; Ireson C; Sattler W
Exp Cell Res; 2013 Aug; 319(13):2037-2048. PubMed ID: 23562655
[TBL] [Abstract] [Full Text] [Related]
11. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract] [Full Text] [Related]
12. Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway.
Deininger MH; Wybranietz WA; Graepler FT; Lauer UM; Meyermann R; Schluesener HJ
FASEB J; 2003 Jul; 17(10):1267-76. PubMed ID: 12832291
[TBL] [Abstract] [Full Text] [Related]
13. The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues.
Akao Y; Marukawa O; Morikawa H; Nakao K; Kamei M; Hachiya T; Tsujimoto Y
Cancer Res; 1995 Aug; 55(15):3444-9. PubMed ID: 7614484
[TBL] [Abstract] [Full Text] [Related]
